The body’s “killer” T cells don’t just attack—they strike with astonishing precision, forming a tiny, highly organized ...

Cytotoxic T lymphocytes are the body's specialized "killer" cells, precisely eliminating infected or cancerous cells. Their ...

When activated by its target, the newly characterized molecule rips the genome apart, a lethal move that researchers can ...

A newly identified weakness in “zombie” cells may open the door to more precise cancer treatments by turning their own ...

Cryo-expansion microscopy has enabled researchers to visualise the three-dimensional organisation of cytotoxic T lymphocytes ...

Chemotherapy kills cancer cells, but it also leaves behind something troubling: damaged cells that stop dividing yet refuse ...

The first clinical trial to test the tumour-fighting power of a stem-cell-like class of long-lived immune cells suggests that ...

Cancer treatment has long been haunted by the same problem: how do you strike dangerous cells without hitting healthy ones nearby? A team at the University of Geneva has built a drug-delivery system ...

Scientists at The Wistar Institute and clinical researchers from ChristianaCare’s Helen F. Graham Cancer Center & Research ...

At AACR 2026, scientists showcased advances in radiotherapeutics, antibody-drug conjugates, T cell engagers, and ...

Cancer cells are known for their “glutamine addiction,” but many can escape this weakness by switching to alternative fuels.

Aspirin reduces the risk of colon cancer recurrence after surgery, but only in patients with a specific genetic marker ...